Tuning mesoporous silica dissolution in physiological environments: a review
Source abstract
Abstract
Matrix degradation has a major impact on the release kinetics of drug delivery systems. Regarding ordered mesoporous silica materials for biomedical applications, their dissolution is an important parameter that should be taken into consideration. In this paper, we review the main factors that govern the mesoporous silica dissolution in physiological environments. We also provide the necessary knowledge to researchers in the area for tuning the dissolution rate of those matrices, so the degradation could be controlled and the material behaviour optimised.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Mesoporous Materials and Catalysis · Layered Double Hydroxides Synthesis and Applications · Catalytic Processes in Materials Science
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. Vallet-Regí M, Rámila A, del Real RP, Pérez-Pariente J (2001) A new property of MCM-41: drug delivery system. Chem Mater 13:308–31110.1021/cm0011559 ↗
2. Vallet-Regí M, Balas F, Arcos D (2007) Mesoporous materials for drug delivery. Angew Chem Int Ed 46:7548–755810.1002/anie.200604488 ↗
3. Wang S (2009) Ordered mesoporous materials for drug delivery. Microporous Mesoporous Mater 117:1–910.1016/j.micromeso.2008.07.002 ↗
4. Manzano M, Colilla M, Vallet-Regí M (2009) Drug delivery from ordered mesoporous matrices. Expert Opin Drug Deliv 6:1–1810.1517/17425240903304024 ↗
5. Yang P, Gai S, Lin J (2012) Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev 41:3679–369810.1039/c2cs15308d ↗
6. Vallet-Regí M, Ruiz-González L, Izquierdo-Barba I, González-Calbet JM (2006) Revisiting silica-based ordered mesoporous materials: medical applications. J Mater Chem 16:26–3110.1039/B509744D ↗
7. Vallet-Regí M, Colilla M, Izquierdo-Barba I (2008) Bioactive mesoporous silicas as controlled delivery systems: application in bone tissue regeneration. J Biomed Nanotechnol 4:1–15
8. Vallet-Regí M, Colilla M, González B (2011) Medical applications of organic–inorganic hybrid materials within the field of silica-based bioceramics. Chem Soc Rev 40:596–60710.1039/C0CS00025F ↗
9. Kresge CT, Leonowicz ME, Roth WJ, Vartuli JC, Beck JS (1992) Ordered mesoporous molecular sieves synthesized by a liquid–crystal template mechanism. Nature 359:710–71210.1038/359710a0 ↗
10. Zhao DY, Feng JL, Huo QS, Melosh N, Fredrickson GH, Chmelka BF, Stucky GD (1998) Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores. Science 279:548–55210.1126/science.279.5350.548 ↗
11. Che S, Liu Z, Ohsuna T, Sakamoto K, Terasaki O, Tatsum T (2004) Synthesis and characterization of chiral mesoporous silica. Nature 429:281–28410.1038/nature02529 ↗
12. Yamauchi Y, Suzukia N, Kimura T (2009) Formation of mesoporous oxide fibers in polycarbonate confined spaces. Chem Commun 38:5689–569110.1039/b909251j ↗
13. Yu CZ, Fan J, Tian BZ, Zhao D, Stucky GD (2002) High-yield synthesis of periodic mesoporous silica rods and their replication to mesoporous carbon rods. Adv Mater 14:1742–174510.1002/1521-4095(20021203)14:23<1742::AID-ADMA1742>3.0.CO;2-3 ↗
14. Kosuge K, Sato T, Kikukawa N, Takemori M (2004) Morphological control of rod- and fiberlike SBA-15 type mesoporous silica using water-soluble sodium silicate. Chem Mater 16:899–90510.1021/cm030622u ↗
15. Soler-Illia GJAA, Innocenzi P (2006) Mesoporous hybrid thin films: the physics and chemistry beneath. Chem Eur J 12:4478–449410.1002/chem.200500801 ↗
16. Sanchez C, Boissiere C, Grosso D, Laberty C, Nicole L (2008) Design, synthesis, and properties of inorganic and hybrid thin films having periodically organized nanoporosity. Chem Mater 20:682–73710.1021/cm702100t ↗
17. Melosh NA, Davidson P, Chmelka BF (2000) Monolithic mesophase silica with large ordering domains. J Am Chem Soc 122:823–82910.1021/ja992801b ↗
18. Naik SP, Fan W, Yokoi T, Okubo T (2006) Synthesis of a three-dimensional cubic mesoporous silica monolith employing an organic additive through an evaporation-induced self-assembly process. Langmuir 22:6391–639710.1021/la060497b ↗
19. Schacht S, Huo Q, Voigt-Martin IG, Stucky GD, Schüth F (1996) Oil-water interface templating of mesoporous macroscale structures. Science 273:768–77110.1126/science.273.5276.768 ↗
20. Lai C-Y, Trewyn BG, Jeftinija DM, Jeftinija K, Xu S, Jeftinija S, Lin VS-Y (2003) A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc 125:4451–445910.1021/ja028650l ↗
21. Vallet-Regí M, Ruiz-Hernández E (2011) Bioceramics: from bone regeneration to cancer nanomedicine. Adv Mater 23:5177–521810.1002/adma.201101586 ↗
22. Wu KC-W, Yamauchi Y (2012) Controlling physical features of mesoporous silica nanoparticles (MSN) for emerging applications. J Mater Chem 22:1251–125610.1039/C1JM13811A ↗
23. Colilla M, González B, Vallet-Regí M (2013) Mesoporous silica nanoparticles for the design of smart delivery nanodevices. Biomater Sci 1:114–13410.1039/C2BM00085G ↗
24. Baeza A, Colilla M, Vallet-Regí M (2015) Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery. Expert Opin Drug Deliv 12:319–33710.1517/17425247.2014.953051 ↗
25. Castillo RR, Colilla M, Vallet-Regí M (2016) Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer. Expert Opin Drug Deliv. doi: 10.1080/17425247.2016.121163710.1080/17425247.2016.1211637 ↗
26. Studer AM, Limbach LK, Van Duc L, Krumeich F, Athanassiou EK, Gerber LC, Moch H, Stark WJ (2010) Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles. Toxicol Lett 197(3):169–17410.1016/j.toxlet.2010.05.012 ↗
27. Vallet-Regí M (2014) Bio-ceramics with clinical applications. Wiley, Chichester10.1002/9781118406748 ↗
28. Terasaki O, Ohsuna T, Liu Z, Sakamoto Y, Garcia-Bennett AE (2004) Structural study of mesoporous materials by electron microscopy. Stud Surf Sci Catal 148:261–28810.1016/S0167-2991(04)80201-5 ↗
29. Czuryszkiewicz T, Ahvenlammi J, Kortesuo P, Ahola M, Kleitz F, Jokinen M, Lindén M, Rosenholm JB (2002) Drug release from biodegradable silica fibers. J Non Cryst Solids 306:1–1010.1016/S0022-3093(02)01060-8 ↗
30. Viitala R, Jokinen M, Tuusa S, Rosenholm JB, Jalonen HJ (2005) Adjustably bioresorbable sol–gel derived SiO2 matrices for release of large biologically active molecules. Sol Gel Sci Technol 36:147–15610.1007/s10971-005-5286-1 ↗
31. Kortesuo P, Ahola M, Kangas M, Kangasniemi I, Yli-Urpo A, Kiesvaara J (2000) In vitro evaluation of sol–gel processed spraydried sillica gel microspheres as carrier in controlled drugdelivery. Int J Pharm 200:223–22910.1016/S0378-5173(00)00393-8 ↗
32. Jokinen M, Peltola T, Veittola S, Rahiala H, Rosenholm JB (2000) Adjustable biodegradation for ceramic fibres derived from silica sols. J Eur Ceram Soc 20:1739–174810.1016/S0955-2219(00)00036-4 ↗
33. Izquierdo-Barba I, Colilla M, Manzano M, Vallet-Regí M (2010) In vitro stability of SBA-15 under physiological conditions. Microporous Mesoporous Mater 132:442–45210.1016/j.micromeso.2010.03.025 ↗
34. He Q, Shi J, Zhu M, Chen Y, Chen F (2010) The three-stage in vitro degradation behavior of mesoporous silica in simulated body fluid. Microporous Mesoporous Mater 131:314–32010.1016/j.micromeso.2010.01.009 ↗
35. Gunawidjaja PN, Mathew R, Lo AYH, Izquierdo-Barba I, García A, Arcos D, Vallet-Regí M, Edén M (2012) Local structures of mesoporous bioactive glasses and their surface alterations in vitro: inferences from solid-state NMR. Phil Trans R Soc A 370:1376–139910.1098/rsta.2011.0257 ↗
36. Choi Y, Lee JE, Lee JH, Jeong JH, Kim J (2015) A biodegradation study of SBA-15 microparticles in simulated body fluid and in vivo. Langmuir 31:6457–646210.1021/acs.langmuir.5b01316 ↗
37. Gouze B, Cambedouzou J, Parrès-Maynadié S, Rébiscoul D (2014) How hexagonal mesoporous silica evolves in water on short and long term: role of pore size and silica wall porosity. Microporous Mesoporous Mater 183:168–17610.1016/j.micromeso.2013.08.041 ↗
38. Izquierdo-Barba I, Ruiz-González L, Doadrio JC, González-Calbet JM, Vallet-Regí M (2005) Tissue regeneration: a new property of mesoporous materials. Solid State Sci 7:983–98910.1016/j.solidstatesciences.2005.04.003 ↗
39. Sakamoto Y, Kim T-W, Ryoo R, Terasaki O (2004) Three-dimensional structure of large-pore mesoporous cubic Ia-3d imaged silica with complementary pores and its carbon replica by electron crystallography. Angew Chem Int Ed 43:5231–523410.1002/anie.200460449 ↗
40. Bass JD, Grosso D, Boissiere C, Belamie E, Coradin T, Sanchez C (2007) Stability of mesoporous oxide and mixed metal oxide materials under biologically relevant conditions. Chem Mater 19:4349–435610.1021/cm071305g ↗
41. Li X, Zhang L, Dong X, Liang J, Shi J (2007) Preparation of mesoporous calcium doped silica spheres with narrow size dispersion and their drug loading and degradation behavior. Microporous Mesoporous Mater 102:151–15810.1016/j.micromeso.2006.12.048 ↗
42. Yan XX, Deng HX, Huang XH, Lu GQ, Qiao SZ, Zhao DY, Yu CZ (2005) Mesoporous bioactive glasses. I. Synthesis and structural characterization. J Non Cryst Solids 351:3209–321710.1016/j.jnoncrysol.2005.08.024 ↗
43. Xia W, Chang J (2006) Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. J Control Release 110:522–53010.1016/j.jconrel.2005.11.002 ↗
44. Diaz A, Lopez T, Manjarrez J, Basaldella E, Martinez-Blanes JM, Odriozola JA (2006) Growth of hydroxyapatite in a biocompatible mesoporous ordered silica. Acta Biomater 2:173–17910.1016/j.actbio.2005.12.006 ↗
45. Maçon ALB, Kim TB, Valliant EM, Goetschius K, Brow RK, Day DE, Hoppe A, Boccaccini AR, Kim IY, Ohtsuki C, Kokubo T, Osaka A, Vallet-Regí M, Arcos D, Fraile L, Salinas AJ, Teixeira Vueva Y, Almeida Miola M, Vitale-Brovarone C, Verné E, Höland E, Jones JR (2015) A unified in vitro evaluation for apatite-forming ability of bioactive glasses and their variants. J Mater Sci Mater Med 26:1–10
46. Turdean-Ionescu C, Stevensson B, Grins J, Izquierdo-Barba I, García A, Arcos D, Vallet-Regí M, Edén M (2015) Composition-dependent in vitro apatite formation at mesoporous bioactive glass-surfaces quantified by solid-state NMR and powder XRD. RSC Adv 5:86061–8607110.1039/C5RA13410B ↗
47. Arcos D, Greenspan DC, Vallet-Regí M (2003) A new quantitative method to evaluate the in vitro bioactivity of melt and sol–gel-derived silicate glasses. J Biomed Mater Res A 65:344–35110.1002/jbm.a.10503 ↗
48. Gunawidjaja PN, Izquierdo-Barba I, Mathew R, Jansson K, García A, Grins J, Arcos D, Vallet-Regí M, Edén M (2012) J Mater Chem 22:7214–722310.1039/c2jm15066b ↗
49. Hench LL, Polak JM (2002) Third-generation biomedical materials. Science 295:1014–101710.1126/science.1067404 ↗
50. García A, Colilla M, Izquierdo-Barba I, Vallet-Regí M (2009) Incorporation of phosphorus into mesostructured silicas: a novel approach to reduce the SiO2 leaching in water. Chem Mater 21:4135–414510.1021/cm9012816 ↗
51. Vallet-Regí M, Izquierdo-Barba I, Rámila A, Pérez-Pariente J, Babonneau F, González-Calbet JM (2004) Phosphorous-doped MCM-41 as bioactive material. Solid State Sci 7:233–23710.1016/j.solidstatesciences.2004.10.038 ↗
52. Huang X, Young NP, Townley HE (2014) Characterization and comparison of mesoporous silica particles for optimized drug delivery. Nanomater Nanotechnol 4:1–1510.5772/58289 ↗
53. Braun K, Pochert A, Beck M, Fiedler R, Gruber J, Lindén M (2016) Dissolution kinetics of mesoporous silica nanoparticles in different simulated body fluids. J Sol Gel Sci Technol 79(2):319–32710.1007/s10971-016-4053-9 ↗
54. Yamada H, Urata C, Aoyama Y, Osada S, Yamauchi Y, Kuroda K (2012) Preparation of colloidal mesoporous silica nanoparticles with different diameters and their unique degradation behavior in static aqueous systems. Chem Mater 24(8):1462–147110.1021/cm3001688 ↗
55. Hao N, Liu H, Li L, Chen D, Li L, Tang F (2012) In vitro degradation behavior of silica nanoparticles under physiological conditions. J Nanosci Nanotechnol 12(8):6346–635410.1166/jnn.2012.6199 ↗
56. Li X, Zhang L, Dong X, Liang J, Shi J (2007) Preparation of mesoporous calcium doped silica spheres with narrow size dispersion and their drug loading and degradation behavior. Microporous Mesoporous Mater 102(1–3):151–15810.1016/j.micromeso.2006.12.048 ↗
57. Fontecave T, Sanchez C, Azaïs T, Boissière C (2012) Chemical modification as a versatile tool for tuning stability of silica based mesoporous carriers in biologically relevant conditions. Chem Mater 24(22):4326–433610.1021/cm302142k ↗
58. Maggini L, Cabrera I, Ruiz-Carretero A, Prasetyanto EA, Robinet E, De Cola L (2016) Nanoscale 8(13):7240–724710.1039/C5NR09112H ↗
59. Cauda V, Schlossbauer A, Bein T (2010) Bio-degradation study of colloidal mesoporous silica nanoparticles: effect of surface functionalization with organo-silanes and poly(ethylene glycol). Microporous Mesoporous Mater 132(1–2):60–7110.1016/j.micromeso.2009.11.015 ↗
60. Cauda V, Argyo C, Bein T (2010) Impact of different PEGylation patterns on the long-term bio-stability of colloidal mesoporous silica nanoparticles. J Mater Chem 20(39):869310.1039/c0jm01390k ↗
61. Paris JL, Cabañas MV, Manzano M, Vallet-Regí M (2015) Polymer-grafted mesoporous silica nanoparticles as ultrasound-responsive drug carriers. ACS Nano 9(11):11023–1103310.1021/acsnano.5b04378 ↗
62. He Q, Zhang Z, Gao F, Li Y, Shi J (2011) In vivo Biodistribution and Urinary Excretion of Mesoporous Silica Nanoparticles: effects of Particle Size and PEGylation. Small 7(2):271–28010.1002/smll.201001459 ↗